Farmakoterapia w Psychiatrii i Neurologii

Pełna treść

3-4/2021 vol. 37
Opis przypadku

Zespół natręctw u pacjenta leczonego kariprazyną w przebiegu schizofrenii z przeważającymi objawami negatywnymi

Agnieszka Koźmin-Burzyńska 1
,
Maciej Matuszczyk 2
,
Marek Krzystanek 1
  1. Department and Clinic of Psychiatric Rehabilitation, Faculty of Medical Sciences, Medical University of Silesia in Katowice
  2. Centrum Zdrowia Psychicznego Tychy, Medforum Sp. z o.o.
Farmakoterapia w Psychiatrii i Neurologii 2021, 37 (3-4): 259-266
DOI: https://doi.org/10.5114/fpn.2021.115645
Data publikacji online: 2022/05/12
Plik artykułu
06R_IPiN_FARM_2021-3D.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Bener A, Dafeeah EE, Abou-Saleh MT, Bhugra D, Ventriglio A. Schizophrenia and co-morbid obsessive - compulsive disorder: Clinical characteristics. Asian J Psychiatr 2018; 37: 80-84.
  2. Bobes J, Arango C, Garcia-Garcia M, Rejas J; CLAMORS Study Collaborative Group. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. J Clin Psychiatry 2010; 71(3): 280-286.
  3. De Berardis D, Vellante F, Fornaro M, Orsolini L, Valchera A, Baroni G et al. Rapid improvement of obsessive-compulsive disorder associated with schizophrenia with cariprazine add-on in a subject under paliperidone long-acting injection: a case report.Int Clin Psychopharmacol 2020; 35(2): 113-118.
  4. Grillault Laroche D, Gaillard A. Induced Obsessive Compulsive Symptoms (OCS) in schizophrenia patients under Atypical 2 Antipsychotics (AAPs): review and hypotheses. Psychiatry Res. 2016; 30; 246: 119-128.
  5. Kokurcan A, Nazlı ŞB. Clinical correlates of obsessive-compulsive disorder comorbidity in patients with schizophrenia. Indian J Psychiatry 2020; 62(1): 51-58.
  6. Krause M, Zhu Y, Huhn M, Schneider-Thoma J, Bighelli I, Nikolakopoulou A et al. Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci 2018; 268(7): 625-639.
  7. Leucht S, Komossa K, Rummel-Kluge Ch, Corves C, Hunger H, Schmid F et al. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am J Psychiatry 2009 Feb; 166(2): 152-63.
  8. Lykouras L, Alevizos B, Michalopoulou P, Rabavilas A. Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27(3): 333-346.
  9. Misiak B, Bieńkowski P, Samochowiec J. Cariprazine – a novel antipsychotic drug and its place in the treatment of schizophrenia. Kariprazyna – nowy lek przeciwpsychotyczny i jego miejsce w leczeniu schizofrenii. Psychiatr Pol 2018; 52(6): 971‐981.
  10. Neill JC, Grayson B, Kiss B, Gyertyán I, Ferguson P, Adham N. Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology. Eur Neuropsychopharmacol 2016; 26(1): 3‐14.
  11. Németh G, Laszlovszky I, Czobor P, Szalai E, Szatmári B, Harsányi J et al. Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial. Lancet. 2017; 389(10074): 1103-1113.
  12. Poyurovsky M, Weizman A, Weizman R. Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. CNS Drugs 2004; 18: 989-1010.
  13. Schirmbeck F, Zink M. Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors. Front Pharmacol 2013; 4: 99.
  14. Szulc A, Dudek D, Samochowiec J, Wojna M, Heitzman J, Gałecki P. Rekomendacje dotyczące leczenia schizofrenii z objawami negatywnymi. Standardy farmakoterapii Polskiego Towarzystwa Psychiatrycznego, część 2. Psychiatr Pol 2019; 53(3): 525-540.
  15. Szulc A, Samochowiec J. Schizofrenia z objawami negatywnymi. PZWL Wydawnictwo Lekarskie, Warszawa 2019.
  16. Tezenas du Montcel C, Pelissolo A, Schürhoff F, Pignon B. Obsessive-Compulsive Symptoms in Schizophrenia: an Up-To-Date Review of Literature. Curr Psychiatry Rep 2019; 21(8): 64.
  17. Vázquez-Bourgon J, Rodríguez-Rodríguez P, Gómez-Ruíz E, Artal J, Crespo-Facorro B. Obsessive-compulsive symptoms induced by long-acting injectable paliperidone in a patient with schizophrenia: a case report. Ann Clin Psychiatry 2014; 26(4): 301-302.
ZGŁASZANIE PRAC
Udostępnij
without publication fees
without publication fees
Zintergrowane z
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications